# Guoyuan Lu

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/guoyuan-lu/

## Facts

| Field | Value |
| --- | --- |
| Citations | 876 |
| Field | Molecular Sensors and Ion Detection |
| h-index | 13 |
| i10-index | 14 |
| Last Known Institution | Soochow University |
| OpenAlex ID | https://openalex.org/A5100610590 |
| Works | 42 |

## Researcher papers

- [Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis](https://scholariq.org/papers/finerenone-in-patients-with-chronic-kidney-disease-and-type-2-diabetes-by-sodium/)
- [Synthesis, DNA‐Binding, Cleavage, and Cytotoxic Activity of New 1,7‐Dioxa‐4,10‐diazacyclododecane Artificial Receptors Containing Bisguanidinoethyl or Diaminoethyl Double Side Arms](https://scholariq.org/papers/synthesis-dna-binding-cleavage-and-cytotoxic-activity-of-new-1-7-dioxa-4-10/)
- [Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes](https://scholariq.org/papers/impact-of-finerenone-induced-albuminuria-reduction-on-chronic-kidney-disease/)
- [Efficacy of Combined <i>Abelmoschus manihot</i> and Irbesartan for Reduction of Albuminuria in Patients With Type 2 Diabetes and Diabetic Kidney Disease: A Multicenter Randomized Double-Blind Parallel Controlled Clinical Trial](https://scholariq.org/papers/efficacy-of-combined-i-abelmoschus-manihot-i-and-irbesartan-for-reduction-of/)
- [DNA Binding and Cleaving Activity of the New Cleft Molecule <i>N</i>,<i>N</i>′-Bis(guanidinoethyl)-2,6-pyridinedicarboxamide in the Absence or in the Presence of Copper(II)](https://scholariq.org/papers/dna-binding-and-cleaving-activity-of-the-new-cleft-molecule-i-n-i-i-n-i-bis/)
- [Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA1c and Insulin Use: An Analysis From the FIDELIO-DKD Study](https://scholariq.org/papers/finerenone-in-patients-with-chronic-kidney-disease-and-type-2-diabetes-according/)
- [Molecular recognition of nucleotides by a calix\[4\]arene derivative with two alkyl guanidinium groups at the air–water interface](https://scholariq.org/papers/molecular-recognition-of-nucleotides-by-a-calix-4-arene-derivative-with-two/)
- [Alteration of circulatory platelet microparticles and endothelial microparticles in patients with chronic kidney disease.](https://scholariq.org/papers/alteration-of-circulatory-platelet-microparticles-and-endothelial-microparticles/)
- [Enantioselective recognition of calix\[4\]arene derivatives bearing chiral bicyclic guanidinium for d/l-phenylalanine zwitterions at the air–water interface](https://scholariq.org/papers/enantioselective-recognition-of-calix-4-arene-derivatives-bearing-chiral/)
- [Supramolecular interaction of diamino calix\[4\]arene derivative with nucleotides at the air–water interface](https://scholariq.org/papers/supramolecular-interaction-of-diamino-calix-4-arene-derivative-with-nucleotides/)
- [Predictors of renal outcomes in crescentic and mixed class of ANCA-associated glomerulonephritis](https://scholariq.org/papers/predictors-of-renal-outcomes-in-crescentic-and-mixed-class-of-anca-associated/)

## Researcher topics

- [Molecular Sensors and Ion Detection](https://scholariq.org/topics/molecular-sensors-and-ion-detection/)
- [Supramolecular Chemistry and Complexes](https://scholariq.org/topics/supramolecular-chemistry-and-complexes/)
- [DNA and Nucleic Acid Chemistry](https://scholariq.org/topics/dna-and-nucleic-acid-chemistry/)
- [Crystallography and molecular interactions](https://scholariq.org/topics/crystallography-and-molecular-interactions/)
- [Hormonal Regulation and Hypertension](https://scholariq.org/topics/hormonal-regulation-and-hypertension/)

## Researcher university

- [Soochow University](https://scholariq.org/institutions/soochow-university-2/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.
